Medtronic begins pediatric clinical trial of spinal tether for treatment of scoliosis

As first patient is enrolled in the clinical trial of braive™ growth modulation system, study reaffirms medtronic's commitment to pediatric spine innovation dublin, sept. 22, 2021 /prnewswire/ -- medtronic plc (nyse: mdt), the global leader in medical technology, today announced that it has enrolled its first patient and completed the first surgical procedure in its braive™ ide study, which will evaluate the safety and effectiveness of the braive™ growth modulation system for treatment of progressive  adolescent idiopathic scoliosis (ais).
MDT Ratings Summary
MDT Quant Ranking